Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut 2013 May; 62 (5): 787-796.
Agustín Layunta F, García Abad MJ, Morales Marina ML. Probióticos, prebióticos y simbióticos. Aplicaciones por patologías. Madrid: Ediciones I; 2017.
Tormo Carnicé R. Probióticos. Concepto y mecanismos de acción. An Pediatr 2006; 4 (1): 30-41.
Peláez Martínez C, Requena Rolanía T. La microbiota intestinal. Madrid: Consejo Superior de Investigaciones Científicas; 2017.
Brandt LJ. Fecal Transplantation for the Treatment of Clostridium difficile Infection. Gastroenterol Hepatol (NY) 2012 Mar; 8 (3): 191–194.
Клинические случаи
Drouault-Holowacz S, Foligné B, Dennin V, et al. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations. Clin Nutr 2006; 25 (6): 994-1003.
Nébot-Vivinus M, Harkat C, Bzioueche H, et al. Multispecies probiotic protects gut barrier function in experimental models. World J Gastroenterol 2014 Jun 14; 20 (22): 6832-6843.
Holowacz S, Guigné C, Chêne G, et al. A multispecies Lactobacillus– and Bifidobacterium-containing probiotic mixture attenuates body weight gain and insulin resistance after a short-term challenge with a high-fat diet in C57/ BL6J mice. Pharma Nutrition 2015 Jul; 3 (3): 101-107.
Holowacz S, Blondeau C, Guinobert I, Guilbot A, Hidal-go-Lucas S, Bisson JF. Antidiarrheal and Antinociceptive Effects of a Probiotic Mixture in Rats. J Prob Health 2016; 4: 155.
Van Hul M, Geurts L, Plovier H, et al. Reduced obesity, diabetes and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier. Am J Physiol Endocrinol Metab 2018 Apr 1; 314 (4): E334-E352.
Holowacz S, Blondeau C, Guinobert I, Guilbot A, Hidalgo S, Bisson JF. Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice. Benef Microbes 2018 Feb 27; 9 (2): 299-309.
Alard J, Peucelle V, Boutillier D, et al. Probiotic strains with a high potential for inflammatory bowel disease management identified by combining in vitro and in vivo approaches. Benef Microbes 2018 Feb 27; 9 (2): 317-331.
Otero W, Gómez M, Otero L, Trespalacios A. Helicobacter pylori: ¿cómo se trata en el 2018? Rev gastroenterol Perú 2018 Ene; 38 (1): 54-63.
Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017; 153 (2): 420-429.
Roach M. Gulp: Adventures on the Alimentary Canal. Nueva York: Norton & Company; 2014.
López-Goñi I. Microbiota. Los microbios de tu organismo. Córdoba: Guadalmazán; 2018.
Peláez Martínez C, Requena Rolanía T. La microbiota intestinal. Madrid: Consejo Superior de Investigaciones Científicas; 2017.
* * *